Ann: MDR Quarterly Report & Appendix 4C, page-2

Boom, Pro froma revenue up 484%. Sales up 80% (40% higher than forecast).

Key highlights
● Purchased Adheris, LLC creating immediate scale in the USA
● Full year CY20 pro-forma revenue of AUD$56m up 484% on CY19 (AUD:USD $0.70)
● MedAdvisor US (incorporating Adheris) achieved USD$19.3m pro-forma in sales for the December half-year (up 85% on the prior corresponding period (p.c.p) and +40% on the Company’s initial forecast of USD$13.8m pro-forma for the half-year)
● Signed contracts to deliver 50%+ of CY21 Adheris earnout revenue hurdle of USD$32.5m (~AUD$40m) and pipeline is strong
● Recognised revenue of AUD$12.8m for the half-year to 31 December 2020, up AUD$8.3m on the p.c.p. (+188%), and AUD$10.3m for the quarter, including the 6 weeks following the Adheris acquisition on 17 November 2020
● Vaccine product was the highest revenue product for CY20, indicating the significant opportunity for MedAdvisor in this space, as programs drive awareness and dose series completion, critical to ensure patients are adequately vaccinated
● Increased operating cash inflows to AUD$14.2m for the half-year to 31 December, up 196% on the p.c.p.
● MedAdvisor (excl. USA) total revenue of AUD$2.7m for the quarter, up 15.4% on p.c.p
● Raised AUD$42.2m equity from a number of existing shareholders, including HMS, and new institutional investors
● Funded to execute integration and growth plans with AUD$21.2m cash at bank

MedAdvisor CEO and Managing Director Robert Read said: “Achieving scale in the US has long been our aspiration given the size of the market and the impact MedAdvisor can have there. We set out to build partnerships and have now made a strategic acquisition at an
attractive price, providing immediate scale in the world’s largest market.
“This quarter validates the strong financial performance of Adheris and the opportunities that are available from MedAdvisor ownership. As a result, our revenues are up 188% year-on-year and approximately 80% of our revenue is now generated in the US. We are now working with our global customers at scale across multiple regions.”